EG19007A - Process for preparing of enantiomeric glutaramide diuretic agents - Google Patents

Process for preparing of enantiomeric glutaramide diuretic agents

Info

Publication number
EG19007A
EG19007A EG25089A EG25089A EG19007A EG 19007 A EG19007 A EG 19007A EG 25089 A EG25089 A EG 25089A EG 25089 A EG25089 A EG 25089A EG 19007 A EG19007 A EG 19007A
Authority
EG
Egypt
Prior art keywords
enantiomeric
preparing
diuretic agents
glutaramide
glutaramide diuretic
Prior art date
Application number
EG25089A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of EG19007A publication Critical patent/EG19007A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/40—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Cosmetics (AREA)
EG25089A 1988-05-19 1989-05-21 Process for preparing of enantiomeric glutaramide diuretic agents EG19007A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888811873A GB8811873D0 (en) 1988-05-19 1988-05-19 Therapeutic agents

Publications (1)

Publication Number Publication Date
EG19007A true EG19007A (en) 1994-11-30

Family

ID=10637176

Family Applications (1)

Application Number Title Priority Date Filing Date
EG25089A EG19007A (en) 1988-05-19 1989-05-21 Process for preparing of enantiomeric glutaramide diuretic agents

Country Status (29)

Country Link
EP (1) EP0342850B1 (de)
JP (1) JPH072699B2 (de)
KR (1) KR920000561B1 (de)
CN (1) CN1015361B (de)
AT (1) ATE76399T1 (de)
AU (1) AU602813B2 (de)
CA (1) CA1331197C (de)
CS (1) CS274502B2 (de)
DD (1) DD283772A5 (de)
DE (1) DE68901582D1 (de)
DK (1) DK172032B1 (de)
EG (1) EG19007A (de)
ES (1) ES2037418T3 (de)
FI (1) FI93541C (de)
GB (1) GB8811873D0 (de)
GR (1) GR3004968T3 (de)
HU (1) HU205067B (de)
IE (1) IE60724B1 (de)
IL (1) IL90267A (de)
MX (1) MX16067A (de)
MY (1) MY104735A (de)
NO (1) NO173647C (de)
NZ (1) NZ229186A (de)
PH (1) PH26740A (de)
PL (1) PL154813B1 (de)
PT (1) PT90584B (de)
SU (1) SU1766251A3 (de)
YU (1) YU47973B (de)
ZA (1) ZA893696B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8812597D0 (en) * 1988-05-27 1988-06-29 Pfizer Ltd Therapeutic agents
GB8820844D0 (en) * 1988-09-05 1988-10-05 Pfizer Ltd Therapeutic agents
GB9000725D0 (en) * 1990-01-12 1990-03-14 Pfizer Ltd Therapeutic agents
EP0644176B1 (de) * 1993-09-22 1995-11-15 Pfizer Limited Hydrierung
US7468390B2 (en) 2002-01-17 2008-12-23 Novartis Ag Methods of treatment and pharmaceutical composition
AR057882A1 (es) 2005-11-09 2007-12-26 Novartis Ag Compuestos de accion doble de bloqueadores del receptor de angiotensina e inhibidores de endopeptidasa neutra
US8993631B2 (en) * 2010-11-16 2015-03-31 Novartis Ag Method of treating contrast-induced nephropathy
KR20200111822A (ko) 2012-08-24 2020-09-29 노파르티스 아게 심방 확장 또는 재형성을 특징으로 하는 질환을 치료하기 위한 nep 억제제
WO2017033128A1 (en) 2015-08-25 2017-03-02 Novartis Ag Biphenyl-substitued 4-amino-butyric acid derivatives and their use in the synthesis of nep inhibitors
WO2017072636A1 (en) 2015-10-29 2017-05-04 Cadila Healthcare Limited Pharmaceutical synergistic combination

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR880007441A (ko) * 1986-12-11 1988-08-27 알렌 제이.스피겔 스피로-치환된 글루타르아미드 이뇨제

Also Published As

Publication number Publication date
MX16067A (es) 1993-10-01
ZA893696B (en) 1990-12-28
GR3004968T3 (de) 1993-04-28
NO173647C (no) 1994-01-12
DE68901582D1 (de) 1992-06-25
IE891613L (en) 1989-11-19
AU602813B2 (en) 1990-10-25
NO173647B (no) 1993-10-04
IE60724B1 (en) 1994-08-10
EP0342850B1 (de) 1992-05-20
CS274502B2 (en) 1991-04-11
YU47973B (sh) 1996-08-13
IL90267A0 (en) 1989-12-15
GB8811873D0 (en) 1988-06-22
DK240889D0 (da) 1989-05-18
ES2037418T3 (es) 1993-06-16
PL279491A1 (en) 1989-11-27
FI892386A (fi) 1989-11-20
AU3490489A (en) 1989-11-23
FI892386A0 (fi) 1989-05-18
FI93541C (fi) 1995-04-25
CA1331197C (en) 1994-08-02
DK240889A (da) 1989-11-20
DD283772A5 (de) 1990-10-24
SU1766251A3 (ru) 1992-09-30
DK172032B1 (da) 1997-09-22
PL154813B1 (en) 1991-09-30
JPH072699B2 (ja) 1995-01-18
ATE76399T1 (de) 1992-06-15
MY104735A (en) 1994-05-31
NO892002D0 (no) 1989-05-18
NZ229186A (en) 1990-10-26
KR920000561B1 (ko) 1992-01-16
NO892002L (no) 1989-11-20
PT90584A (pt) 1989-11-30
FI93541B (fi) 1995-01-13
HUT53596A (en) 1990-11-28
HU205067B (en) 1992-03-30
PT90584B (pt) 1994-09-30
YU102289A (en) 1991-06-30
KR900017993A (ko) 1990-12-20
CS296589A2 (en) 1990-09-12
EP0342850A1 (de) 1989-11-23
CN1015361B (zh) 1992-02-05
IL90267A (en) 1993-08-18
JPH0222256A (ja) 1990-01-25
PH26740A (en) 1992-09-28
CN1037704A (zh) 1989-12-06

Similar Documents

Publication Publication Date Title
IL111843A0 (en) Preparation of 3,4,4-trisubstituted-piperidinyl-n-alkylcarboxylates and intermediates
IL88798A0 (en) Process and intermediates for the synthesis of 1,2-dioxetanes
EG19007A (en) Process for preparing of enantiomeric glutaramide diuretic agents
IL75812A (en) Process for the preparation of halogenated quinolone-carboxylic acids,and 7-chloro-1-cyclopropyl 1,4-dihydro-4-oxo-3-quinoline-carboxylic acid nitrile intermediates therefor
IL89535A0 (en) Process and novel intermediates for the preparation of 1-cyclopropyl-quinolone-carboxylic acids and their derivatives
IE873288L (en) Derivatives of bicyclic aminocarboxylic acids.
EG19767A (en) Process for preparing of substituted 1,2,4- triazinediones intermediates therefor and their use
IL77661A (en) Process for the preparation of 4,4-azetidinones,and novel intermediates thereof
GB2210040B (en) The new process for the preparation of 3-(4'-bromobiphenyl-4-yl) tetralin-1-one
AU4552489A (en) Amine salts of 1,4,2-oxazaphospholidine-4-acetic acid, 2-alkoxy-2-oxides
PT85023A (en) Process for the preparation of substituted 2-phenylacetil-1,3,5-cyclohexanetriones and of intermediates
PT80359A (en) (6,11-dihydro-11-oxodibenz<b,e>oxepinyl)pentanoic acids and derivatives a process and intermediates for their preparation and their use as medicaments
AU1917988A (en) New derivatives of pyrethrinoids containing a nitrogenous heterocycle, their process and intermediates of preparation, their use as pesticides and the compositions containing them
RO105809B1 (ro) PROCEDEU PENTRU PREPARAREA bis-N,N'-(DIMETILFORMAMIDO)
AU2272788A (en) 2,6-methanopyrrolo-3-benzazocines, a process and intermediates for their preparation and their use as medicaments
PT80905A (en) Process for preparing 2,5-pyrrolidindione derivatives useful as antiarrhythmic agents
IE880203L (en) Optically active beta-methylcholine
EP0338494A3 (de) 3-Anilino-2-hydroxycarbonyl-4-thiophenessigsäuren
EP0338493A3 (de) Tetrahydro-4-phenylimino-3-thiophenessigsäuren
ZA883610B (en) A process for the preparation of 5-acylamino-2,4,6-triiodo-or tribromo-benzioc acid derivatives and the acid derivatives obtained by said process
PT81459A (en) Process for the obtention of 4-alkyloxi-2-methyl-2h-thieno 2,3--and -1,2-tiazine-1,1-dioxide-3-carboxylics acids